Latest Schedule 13D activist filings
NASDAQ
NCPL
Netcapital INCStrategic EP, LLC and Alexander Chase Deitch have acquired a 5.8% stake in Netcapital Inc., intending to push for a high-value accretive transaction.
NASDAQ
ValueAct Capital Master Fund and related entities have reduced their beneficial ownership in Insight Enterprises, Inc. to 4.7%, triggering the termination of their Schedule 13D filing obligation.
Lingtao Kong's beneficial ownership in Ridgetech Inc. now stands at 12.2% due to an increase in outstanding shares, with no personal share transactions since March 2025.
NYSE
CDLR
Cadeler A/sSCHEDULE: BW Altor Boosts Cadeler Stake to 27.44%
BW Altor Pte. Ltd. has increased its beneficial ownership in Cadeler A/S to 27.44% through recent share acquisitions totaling over 17.6 million shares.
NYSE
Sit Investment Associates and Sit Fixed Income Advisors II report a 47.5% beneficial ownership stake in Putnam Master Intermediate Income Trust, detailing recent share transactions.
NYSE
CVEO
Civeo CORPEngine Capital and Civeo Corp have entered a Cooperation Agreement, leading to the appointment of two Engine Capital nominees to Civeo's Board of Directors.
NASDAQ
NDLS
Noodles & COGalloway Capital Partners, LLC and affiliates have disclosed a 6.01% stake in Noodles & Co, stating the company's shares are undervalued and management needs to protect equity value.
NYSE
ASH
Ashland INCStandard Investments and its affiliates have disclosed a 5.7% beneficial ownership stake in Ashland Inc., signaling potential engagement on strategic and governance matters.
NYSE
NRDY
Nerdy INCNerdy Inc.'s CEO and Chairman, Charles Cohn, along with his spouse Allison Cohn, have significantly increased their beneficial ownership in the company through recent open market purchases.
Scilex Holding Company has increased its beneficial ownership in Datavault AI Inc. to 47.99% after purchasing and exercising a pre-funded warrant for approximately $141.9 million in Bitcoin.
NASDAQ
Scilex Holding Company has significantly increased its beneficial ownership in Datavault AI Inc. to 47.99% after purchasing and exercising a Pre-Funded Warrant.
NASDAQ
Castle Creek Capital Partners VII, LP has significantly reduced its stake in CF Bankshares Inc., selling 81,617 shares for nearly $2 million.
NASDAQ
SCHEDULE 13D/A: Republic Airways Completes Merger, United Forgives Debt
Republic Airways Holdings Inc. (formerly Mesa Air Group, Inc.) has completed its merger with Legacy Republic, with United Airlines Holdings Inc. forgiving significant debt and entering a 10-year service agreement.
SCHEDULE 13D/A: Republic Airways Completes Merger, United Forgives Debt
Republic Airways Holdings Inc. finalized its merger with Legacy Republic, resulting in United Airlines Holdings, Inc. holding an 18.2% stake and forgiving significant debt.
NASDAQ
Pangaea Logistics Solutions Ltd. has entered into an agreement with major shareholder Strategic Shipping Inc., leading to a board expansion and the appointment of Paul M. Leand, Jr. as a new director.
An activist investor group, led by Gabriel Gliksberg, has filed a Schedule 13D, challenging Nabors Energy Transition Corp. II's plan to allocate assets from a failed transaction, arguing it's improper and inconsistent with fiduciary duties.
RENB
Renovaro INCSCHEDULE 13D/A: Wittekind's Lunai Bioworks Stake Dips to 6.8%
William Anderson Wittekind's beneficial ownership in Lunai Bioworks Inc. decreased to 6.8% following the Issuer's recent share sale.
NASDAQ
SCHEDULE 13D/A: Casdin Entities Boost Standard BioTools Stake to 24.2%
Casdin Capital and affiliated funds have increased their beneficial ownership in Standard BioTools Inc. to 24.2% through recent open market purchases.
NASDAQ
SCHEDULE 13D/A: General Atlantic Exits Centessa Pharmaceuticals Stake
General Atlantic and its affiliated entities have filed an exit amendment to their Schedule 13D, reporting their beneficial ownership in Centessa Pharmaceuticals plc has fallen below 5% after recent open market sales.
NYSE
SCHEDULE 13D/A: QH Hungary Amends Share Forward Deals, Raises Capital
QH Hungary Holdings Limited updated its Schedule 13D filing, detailing amendments to existing prepaid variable share forward transactions and new agreements with Citibank and Royal Bank of Canada to extend settlement dates and raise financing.
NASDAQ
SCHEDULE 13D/A: Manning Boosts Verrica Stake to 49.9% After Unit Purchases
Paul B. Manning and affiliated entities increased their beneficial ownership in Verrica Pharmaceuticals Inc. to 49.9% through recent purchases of common stock and warrants.
NASDAQ
LCID
Lucid Group, INCSCHEDULE 13D/A: Lucid Group Secures $975M Notes, PIF Affiliate Boosts Stake
Lucid Group, Inc. announced the closing of $975 million in convertible senior notes and a PIF affiliate's prepaid forward purchase of 37.48 million shares.
SCHEDULE 13D/A: Guild Holdings Co. Delists After Merger Completion
Guild Holdings Co. has completed its merger, resulting in its delisting from the NYSE and termination of SEC reporting obligations.
NASDAQ
AIMD
Ainos, INCSCHEDULE 13D/A: Ainos KY Boosts Voting Power in Ainos, Inc.
Ainos Inc. (Cayman Islands) increased its sole voting power in Ainos, Inc. (Texas) to 3,585,354 shares, representing 8.52% of the class, following special stock awards and existing voting agreements.
NASDAQ
AIMD
Ainos, INCSCHEDULE 13D: Director Chun-Jung Tsai Discloses 6% Stake in Ainos Inc.
Ainos Inc. Director Chun-Jung Tsai has reported beneficial ownership of 356,999 shares, representing 6% of the company's common stock, acquired through stock awards and subject to a voting agreement with Ainos KY.
NASDAQ
AIMD
Ainos, INCSCHEDULE 13D/A: Ainos CEO Tsai Boosts Stake with 80,000 Stock Award
Ainos, Inc.'s CEO, President, and Chairman, Chun-Hsien Tsai, increased his beneficial ownership to 7% after receiving 80,000 fully vested special stock awards.
NASDAQ
AIMD
Ainos, INCSCHEDULE 13D/A: Ainos Insider Boosts Stake with Special Stock Award
Ting Chuan Lee, a reporting person for Ainos, Inc., increased beneficial ownership to 6% after receiving 80,000 fully vested common stock shares as a special award.
SCHEDULE 13D/A: Lynx1 Capital to Resubmit Neuphoria Buyout Offer
Lynx1 Capital Management plans to resubmit a revised offer to acquire Neuphoria Therapeutics Inc. after the company ceased its dilutive share issuances.
NASDAQ
SCHEDULE 13D/A: Insider Sells Collplant Shares, Ownership Drops to 12.9%
Ami Sagy, a significant beneficial owner, has reduced his stake in Collplant Biotechnologies Ltd. by selling 140,000 ordinary shares, bringing his total ownership to 12.9%.
NASDAQ
SCHEDULE 13D: Director Boosts ENDRA Life Sciences Stake to 9.99%
Anthony DiGiandomenico, a director at ENDRA Life Sciences Inc., has increased his beneficial ownership to 9.99% of the company's common stock.